APA (7th ed.) Citation

Higuchi, Y., Suzuki, T., Arimori, T., Ikemura, N., Mihara, E., Kirita, Y., . . . Hoshino, A. (2021). Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2. Nature communications, 12(1), 3802-13. https://doi.org/10.1038/s41467-021-24013-y

Chicago Style (17th ed.) Citation

Higuchi, Yusuke, et al. "Engineered ACE2 Receptor Therapy Overcomes Mutational Escape of SARS-CoV-2." Nature Communications 12, no. 1 (2021): 3802-13. https://doi.org/10.1038/s41467-021-24013-y.

MLA (9th ed.) Citation

Higuchi, Yusuke, et al. "Engineered ACE2 Receptor Therapy Overcomes Mutational Escape of SARS-CoV-2." Nature Communications, vol. 12, no. 1, 2021, pp. 3802-13, https://doi.org/10.1038/s41467-021-24013-y.